Indegene Limited (NSE: INDGN)

India flag India · Delayed Price · Currency is INR
590.00
+1.20 (0.20%)
Dec 24, 2024, 3:29 PM IST
-9.92%
Market Cap 141.17B
Revenue (ttm) 27.10B
Net Income (ttm) 3.73B
Shares Out 239.27M
EPS (ttm) 16.17
PE Ratio 36.48
Forward PE 35.82
Dividend n/a
Ex-Dividend Date n/a
Volume 701,375
Open 589.50
Previous Close 588.80
Day's Range 588.05 - 605.00
52-Week Range 470.10 - 736.30
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 27, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor... [Read more]

Industry Medical-Healthcare Information Services
Sector Healthcare
Founded 1998
Employees 4,367
Stock Exchange National Stock Exchange of India
Ticker Symbol INDGN
Full Company Profile

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.

Financial Statements

News

There is no news available yet.